The relationship between ApoA5 and plasma TG metabolism has been well established; however, the influence of ApoA5 on NAFLD and atherosclerotic cardiovascular disease (ASCVD) has remained largely elusive. The gene discussed is APOA5; the disease is atherosclerosis.